We’ve issued a new notice: NIGMS Support to Utilize Data and Biospecimens Generated by the ARDS, Pneumonia, and Sepsis (APS) Phenotyping Consortium (NOT-GM-24-018). The purpose is to inform investigators that we’ll support studies that fall within the NIGMS mission and utilize biospecimens or data generated from the APS Consortium.
Investigators can learn about the study design and structure of the APS Consortium in our previous Feedback Loop post. The APS public
website, maintained by Consortium investigators, will have information about the available data and biospecimens and a process for requesting access during the active phase of the study. After that time, these resources will be under the stewardship of National Heart, Lung, and Blood Institute (NHLBI) repositories (e.g., BioLINCC, BioDataCatalyst), which have established processes to request data and samples.
Investigators who currently hold NIGMS awards with relevant aims or a flexible research scope (e.g., Maximizing Investigators’ Research Awards), or those who intend to apply for new NIGMS funding, may request data and biospecimens from the APS Consortium or the above NHLBI repositories as available.
NIGMS will accept new applications utilizing APS-generated data or biospecimens as detailed in the notice. Investigators are always advised to contact program staff to confirm the proposed studies fall within the scientific scope of their awards (if ongoing) and the NIGMS mission.
Please contact me with any questions regarding this notice.